Arrowhead Pharmaceuticals
ARWR
#2768
Rank
A$9.03 B
Marketcap
A$63.92
Share price
-2.76%
Change (1 day)
3.37%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2026 (TTM): A-$4.90

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$4.95. In 2025 the company made an earnings per share (EPS) of A-$0.01487 an increase over its 2024 EPS that were of A-$7.43.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$4.9032841.93%
2025A-$0.01487-99.8%
2024A-$7.43161.39%
2023A-$2.8417.36%
2022A-$2.4219.85%
2021A-$2.0261.9%
2020A-$1.25-216.67%
2019A$1.07-210.77%
2018A-$0.9738.3%
2017A-$0.70-64.93%
2016A-$1.99-16.25%
2015A-$2.3828%
2014A-$1.86-3.85%
2013A-$1.93-31.58%
2012A-$2.83331.82%
2011A-$0.65-51.11%
2010A-$1.34-79.07%
2009A-$6.39-37.68%
2008A-$10.26-16.87%
2007A-$12.3438.33%
2006A-$8.92122.22%
2005A-$4.0142.11%
2004A-$2.83533.33%
2003A-$0.45-99.08%
2002A-$48.2825%
2001A-$38.6233.33%
2000A-$28.97-120%
1999A$144.83-400%
1998A-$48.28-81.48%
1997A-$260.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.93-300.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
A-$11.88 139.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$3.85-177.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$29.46-694.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
A-$2.72-45.05%๐Ÿ‡บ๐Ÿ‡ธ USA